# Gabriela Kaynor

> Gabriela Kaynor is a Series D investor at Olympus Corporation backing Biopharma and Health Care. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Olympus Corporation](https://shizune.co/investors/profile/olympus-corporation)
- Total investments: 1
- Last investment: Jul 2024
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/gabrielakaynor

Gabriela Kaynor is a Series D investor at Olympus Corporation focused on Biopharma and Health Care. Gabriela Kaynor is the President of Olympus Innovation Ventures and Chief Strategy Officer at Olympus Corporation.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 1 | 100% |
| Health Care | 1 | 100% |
| Medical Device | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| NeuSpera Medical | NeuSpera Medical develops implantable medical device technology to treat chronic illnesses through minimally invasive solutions. NeuSpera focuses on bioelectronic medicine and has developed ultra-miniaturized implants using their proprietary Mid-Field Powering technology. This technology allows the implants to be powered externally, enabling deeperand more reliable neuromodulation treatments for conditions like Urinary Urgency Incontinence (UUI) and chronic peripheral nerve pain | $23M | Series D | Jul 15, 2024 |  |

1 of 1 investments shown.

## Co-investors
- [Action Potential Venture Capital](https://shizune.co/investors/profile/action-potential-venture-capital) — VC Fund, 1 deal together
- [Treo Ventures](https://shizune.co/investors/profile/strategic-healthcare-investment-partners) — VC Fund, 1 deal together
- [Vertex Ventures HC](https://shizune.co/investors/profile/vertex-ventures-hc) — VC Fund, 1 deal together
- [Windham Venture Partners](https://shizune.co/investors/profile/windham-venture-partners) — VC Fund, 1 deal together

## About Olympus Corporation

VC Fund · Tokyo, Japan

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates in four segments: Medical, Scientific, Imaging, and Others. The medical business segment provides endoscopy systems comprising videoscopes, video processors, light sources, and liquid crystal display panels; peripheral equipment such asimage recording devices, endoscope cleaning systems, and sterilization systems; surgical video endoscopy systems and peripheral devices for endoscopic surgery, electrosurgical knives and more.; and endoscopic devices for various diagnostic and treatment procedures, including biopsy forceps, high-frequency polypectomy snares, grasping forceps, stone retrieval and lithotriptor baskets, and hemostasis accessories.The scientific solutions business segment offers upright and polarizing microscopes, inverted microscopes, laser confocal microscopes, box-type fluorescence imaging devices, stereo microscopes, fluorescence macro microscopes, microscope digital cameras, imaging software, bio-imaging systems, and virtual slide systems; and metallurgical microscopes, semiconductor inspection microscopes, laser and measuring microscopes, microscopic 3D measurement systems, industrial videoscopes and fiberscopes, industrial rigid scopes, ultrasonic flaw detectors, eddy current flaw detectors, phased array flaw detectors, X-ray diffraction analyzers, and peripheral equipment. The imaging business segment offers digital single-lens cameras, compact digital cameras and related products, digital camera lens barrels, and optical components as well as IC recorders and binoculars. The Others Business segment manufactures biomedical materials as well as conducts system development and other business activities.Olympus Corporation was founded by Takeshi Yamashita in October 1919 and is headquartered in Tokyo, Japan.

5 contacts available at Olympus Corporation.

| Name | Title | Profile |
| --- | --- | --- |
| Andre Roggan | Executive Managing Director & Chairman of the Board | https://shizune.co/investors/profile/andre-roggan |
| Chikashi Takeda | Chief Financial Officer | https://shizune.co/investors/profile/chikashi-takeda-1f3b |
| Gabriela Kaynor | Chief Strategy Officer (CSO)/ Executive Officer | https://shizune.co/investors/profile/gabriela-kaynor-4fd1 |
| Kenneth Olsen | Global Associate General Counsel, Regulatory Law | https://shizune.co/investors/profile/kenneth-olsen-f442 |
| Michael Speiser | Managing Director | https://shizune.co/investors/profile/michael-speiser |

## Similar investors

### Similar stage
- [Sigma Partners](https://shizune.co/investors/profile/sigma-partners) — VC Fund
- [EDBI](https://shizune.co/investors/profile/edbi) — VC Fund
- [Trifecta Capital Advisors](https://shizune.co/investors/profile/trifecta-capital-advisors) — VC Fund

## FAQ

### What does Gabriela Kaynor invest in?

Gabriela Kaynor invests primarily in Biopharma, Health Care and Medical Device startups, most often at Series D stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Gabriela Kaynor last invest?

The most recent investment recorded for Gabriela Kaynor closed in Jul 2024. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co